Employer record no. 12391
Verve Therapeutics, Inc.
US DOL LCA disclosure data, FY2020 to FY2025
Total LCA filings
29
Certified
26
Denied
2
FY2025 filings
6
Filings by fiscal year
Peer rank
#1,020 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 4 | 2 | 2 | $90,822 | $85,520 |
| FY2021 | 1 | 1 | 0 | $59,259 | $59,259 |
| FY2022 | 3 | 3 | 0 | $91,748 | $89,086 |
| FY2023 | 9 | 9 | 0 | $105,934 | $89,052 |
| FY2024 | 6 | 6 | 0 | $117,800 | $81,786 |
| FY2025 | 6 | 5 | 0 | $123,209 | $122,845 |
What they file for
- associate scientist, formulations$90,0003
- associate scientist, editing & discovery$97,0002
- senior manager, analytical cmc$132,8982
- associate scientist, editor development$94,0001
- associate scientist, off target sciences$100,0001
- associate scientist, preclinical pharmacology$90,0001
- associate scientist, rna technology & engineering$107,0001
- manager, next generation sequencing$140,7951
Where
- boston, ma21
- cambridge, ma7
- somerville, ma1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Verve Therapeutics, Inc. and any other employer they watch.
Certification rate 89.7%How these numbers are computed